effects of tirzepatide on pregnancy (Zepbound) for weight loss Tirzepatide and Pregnancy: Safety Facts

doi: 10.1007/s10695-005-0266-5 79 WeissburgM.SmeeD

12 , e12278 (2024)

Several nutritional pitfalls commonly occur when individuals begin GLP-1 therapy, potentially compromising health outcomes or treatment efficacy

Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults (as Zepbound)

GLP-1 receptor agonists work by mimicking hormones that signal fullness

However, to purchase Zepbound (Mounjaro) and the injectable pens required for four weeks would cost around 300 with Second Nature when its available